Literature DB >> 31733553

Bioavailability and cytotoxicity of Cerium- (IV), Copper- (II), and Zinc oxide nanoparticles to human intestinal and liver cells through food.

Jinxing Li1, Yuchao Song2, Rolf David Vogt3, Yuankun Liu2, Jipeng Luo2, Tingqiang Li4.   

Abstract

Anthropogenic nanoparticles (NPs) are emitted to the environment and may be present in vegetables for human consumption. However, the toxicity of NPs exposure through food lack systematical investigations. In order to propose a systematical study, lettuce grown in a Cerium- (IV), Copper- (II) and Zinc oxide NP contaminated environment were digested. This digestate was used to culture human intestine cells (i.e. epithelial colorectal adenocarcinoma cells, Caco-2). The basolateral juice produced by the intestinal cells was then used to culture normal human liver (HL-7702) cells. Bioavailability and biotoxicity of the NPs in the vitro models were assessed. NPs were found to be taken up from the environment by vegetables, and may thus be transferred to humans through oral exposure. Bioavailability and the effect of their concentration in the digestate medium differed in regards to NP materials. The levels of NPs found in the digestate were detrimental to intestine cells, while the liver cells exposed to lower concentrations of NP in the bodily fluid showed no statically significant change in cell necrosis. A closer assessment of the detrimental effect of the studied NPs to Caco-2 cells revealed that the damage was mainly related to the solubility of the NPs. This may partly be due to that the more soluble NP material (ZnO > CuO > CeO2) render higher metal ion release and thus higher bioavailability. This appeared to cause more cell death, and even lead to local intestinal inflammation. Although no liver cells died, there was an increase of ROS level, causing ROS-related DNA damage prior to cell necrosis. The findings in this study enhances our understanding of the relative detrimental effect of different types of NPs, and the mechanisms causing their biotoxicity in human cells through food.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bioavailability; Biotoxicity; In vitro; NPs in vegetable

Year:  2019        PMID: 31733553     DOI: 10.1016/j.scitotenv.2019.134700

Source DB:  PubMed          Journal:  Sci Total Environ        ISSN: 0048-9697            Impact factor:   7.963


  6 in total

1.  Lethality of Zinc Oxide Nanoparticles Surpasses Conventional Zinc Oxide via Oxidative Stress, Mitochondrial Damage and Calcium Overload: A Comparative Hepatotoxicity Study.

Authors:  Xingyao Pei; Haiyang Jiang; Gang Xu; Cun Li; Daowen Li; Shusheng Tang
Journal:  Int J Mol Sci       Date:  2022-06-16       Impact factor: 6.208

2.  Impact of in vitro digested zinc oxide nanoparticles on intestinal model systems.

Authors:  Anna Mittag; Alina Singer; Christian Hoera; Martin Westermann; Alexander Kämpfe; Michael Glei
Journal:  Part Fibre Toxicol       Date:  2022-05-30       Impact factor: 9.112

Review 3.  Reactive Oxygen Species-Related Nanoparticle Toxicity in the Biomedical Field.

Authors:  Zhongjie Yu; Qi Li; Jing Wang; Yali Yu; Yin Wang; Qihui Zhou; Peifeng Li
Journal:  Nanoscale Res Lett       Date:  2020-05-20       Impact factor: 4.703

4.  Oral Exposure to ZnO Nanoparticles Disrupt the Structure of Bone in Young Rats via the OPG/RANK/RANKL/IGF-1 Pathway.

Authors:  Xinyue Xu; Yizhou Tang; Yuanyuan Lang; Yanling Liu; Wenshu Cheng; Hengyi Xu; Yang Liu
Journal:  Int J Nanomedicine       Date:  2020-12-03

5.  Cellular Uptake and Toxicological Effects of Differently Sized Zinc Oxide Nanoparticles in Intestinal Cells.

Authors:  Anna Mittag; Christian Hoera; Alexander Kämpfe; Martin Westermann; Jochen Kuckelkorn; Thomas Schneider; Michael Glei
Journal:  Toxics       Date:  2021-04-27

6.  Artificial Digestion of Polydisperse Copper Oxide Nanoparticles: Investigation of Effects on the Human In Vitro Intestinal Co-Culture Model Caco-2/HT29-MTX.

Authors:  Jevin Büttner; Thomas Schneider; Martin Westermann; Michael Glei
Journal:  Toxics       Date:  2022-03-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.